BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 30315892)

  • 1. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
    Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
    Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 5. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 9. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria.
    Senhaji-Kacha A; Akir A; Broncano-Lavado A; Esteban J
    Rev Esp Quimioter; 2024 Jun; 37(3):266-269. PubMed ID: 38602224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of
    Shakoor S; Shafiq S; Shahid A; Mir F; Ali R; Hasan R
    Int J Mycobacteriol; 2023; 12(3):310-315. PubMed ID: 37721238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.
    Johansen MD; Herrmann JL; Kremer L
    Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
    Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
    Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontuberculous Mycobacteria-Overview.
    Koh WJ
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28128073
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
    Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL
    Clin Infect Dis; 2020 Aug; 71(4):e1-e36. PubMed ID: 32628747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.